Regulatory Resources
Clinical guidelines, MDCG guidance, FDA guidance, standards, and compliance tools
Bronchiolitis in children: diagnosis and management
Clinical Guideline by NICE in Respiratory & Intensive Care (2015).
Download PDFBronchiectasis (non-cystic fibrosis), acute exacerbation: antimicrobial prescribing
Clinical Guideline by NICE in Respiratory & Intensive Care (2018).
Download PDFBrain tumours (primary) and brain metastases in over 16s
Clinical Guideline by NICE in Neurology & Neurosurgery (2018).
Download PDFBorderline personality disorder: recognition and management
Clinical Guideline by NICE in Neurology & Neurosurgery (2009).
Download PDFBlood transfusion
Clinical Guideline by NICE in Oncology & Haematology (2015).
Download PDFBehaviour change: digital and mobile health interventions
Clinical Guideline by NICE in Public Health & Primary Care (2020).
Download PDFBedwetting in under 19s
Clinical Guideline by NICE in Paediatrics (2010).
Download PDFBarrett’s oesophagus and stage 1 oesophageal adenocarcinoma: monitoring and management
Clinical Guideline by NICE in Gastroenterology & Hepatology (2023).
Download PDFBabies, children and young people’s experience of healthcare
Clinical Guideline by NICE in Paediatrics (2021).
Download PDFBrazil ANVISA — RDC No. 751/2022 — Medical Device Registration
ANVISA RDC 751/2022, effective March 2023, governs medical device registration in Brazil with a risk classification aligned to EU MDR classes I–III. Replaced RDC 185/2001.
Download PDF